Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: A longitudinal epidemiological and clinical study

The Lancet Infectious Diseases

Volumn 13, Issue 10, 2013, Pages 867-876

  Edelstein, Mikhail V ^a   Skleenova, Elena N ^a   Shevchenko, Oksana V ^a   D'souza, Jimson W ^a   Tapalski, Dmitry V ^b   Azizov, Ilya S ^c   Sukhorukova, Marina V ^a   Pavlukov, Roman A ^a   Kozlov, Roman S ^a   Toleman, Mark A ^d   Walsh, Timothy R ^d  

^a SMOLENSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^b GOMEL STATE MEDICAL UNIVERSITY   (Belarus)

^c KARAGANDA STATE MEDICAL UNIVERSITY   (Kazakhstan)

^d Heath Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; DORIPENEM; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; TAZOBACTAM;

ADOLESCENT; ADULT; AGAR DILUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BELARUS; CHILD; CLONAL VARIATION; FEMALE; GENE CASSETTE; GENE LOCUS; GENE SEQUENCE; HUMAN; INFANT; INTEGRON; KAZAKHSTAN; MAJOR CLINICAL STUDY; MALE; METALLO BETA LACTAMASE GENE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RUSSIAN FEDERATION; SCHOOL CHILD; SPECIES IDENTIFICATION;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KAZAKHSTAN; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REPUBLIC OF BELARUS; RISK FACTORS; RUSSIA; TIME FACTORS; YOUNG ADULT;

EID: 84884417713     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70168-3     Document Type: Article

References (44)

1. Coggan KA, Wolfgang MC Global regulatory pathways and cross-talk control Pseudomonas aeruginosa environmental lifestyle and virulence phenotype. Curr Issues Mol Biol 2012, 14:47-70.
2. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pan-drug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18:268-281.
3. Lim TP, Lee W, Tan TY, et al. Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin B. PLoS One 2011, 6:e28177.
4. Cabot G, Ocampo-Sosa AA, Domínguez MA, et al. Spanish Network for Research in Infectious Diseases (REIPI). Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones. Antimicrob Agents Chemother 2012, 56:6349-6357.
5. Cornaglia G, Giamarellou H, Rossolini GM Metallo-β-lactamases: a last frontier for β-lactams?. Lancet Infect Dis 2011, 11:381-393.
6. Jabes D The antibiotic R&D pipeline: an update. Curr Opin Microbio 2011, 14:564-569.
7. Biswas S, Brunel JM, Dubus JC, Reynaud-Gaubert M, Rolain JM Colistin: an update on the antibiotic of the 21st century. Expert Rev Anti Infect Ther 2012, 10:917-934.
8. Poirel L, Naas T, Nicolas D, et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 2000, 44:891-897.
9. Cardoso O, Leitão R, Figueiredo A, Sousa JC, Duarte A, Peixe LV Metallo-β-lactamase VIM-2 in clinical isolates of Pseudomonas aeruginosa from Portugal. Microb Drug Resist 2002, 8:93-97.
10. Walsh TR Clinically significant carbapenemases: an update. Curr Opin Infect Dis 2008, 21:367-371.
11. Khosravi Y, Tay ST, Vadivelu J Analysis of integrons and associated gene cassettes of metallo-β-lactamase-positive Pseudomonas aeruginosa in Malaysia. J Med Microbiol 2011, 60:988-994.
12. Van der Bij AK, Van der Zwan D, Peirano G, et al. Metallo-β-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type. Clin Microbiol Infect 2012, 18:E369-E372. MBL-PA Surveillance Study Group.
13. Jovcic B, Vasiljevic Z, Djukic S, Topisirovic L, Kojic M Emergence of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa isolates in a paediatric hospital in Serbia. J Med Microbiol 2011, 60:868-869.
14. Lee K, Lim YS, Yong D, Yum JH, Chong Y Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp and Acinetobacter spp. J Clin Microbiol 2003, 41:4623-4629.
15. Yong D, Toleman MA, Bell J, et al. Genetic and biochemical characterization of an acquired subgroup B3 metallo-β-lactamase gene, blaAIM-1, and its unique genetic context in Pseudomonas aeruginosa from Australia. Antimicrob Agents Chemother 2012, 56:6154-6159.
16. Fiett J, Baraniak A, Mrówka A, et al. Molecular epidemiology of acquired-metallo-β-lactamase-producing bacteria in Poland. Antimicrob Agents Chemother 2006, 50:880-886.
17. Toleman MA, Vinodh H, Sekar U, Kamat V, Walsh TR blaVIM-2-harboring integrons isolated in India, Russia, and the United States arise from an ancestral class 1 integron predating the formation of the 3' conserved sequence. Antimicrob Agents Chemother 2007, 51:2636-2638.
18. Onteniente L, Brisse S, Tassios PT, Vergnaud G Evaluation of the polymorphisms associated with tandem repeats for Pseudomonas aeruginosa strain typing. J Clin Microbiol 2003, 41:4991-4997.
19. DeWoody JA, Schupp J, Kenefic L, Busch J, Murfitt L, Keim P Universal method for producing ROX-labeled size standards suitable for automated genotyping. Biotechniques 2004, 37:348-352.
20. Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol 2004, 42:5644-5649.
21. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010, 10:597-602.
22. Lolans K, Queenan AM, Bush K, Sahud A, Quinn JP First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-β-lactamase (VIM-2) in the United States. Antimicrob Agents Chemother 2005, 49:3538-3540.
23. Yan JJ, Hsueh PR, Lu JJ, Chang FY, Ko WC, Wu JJ Characterization of acquired β-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons. J Antimicrob Chemother 2006, 58:530-536.
24. Samuelsen O, Toleman MA, Sundsfjord A, et al. Molecular epidemiology of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob Agents Chemother 2010, 54:346-352.
25. Gillings MR, Labbate M, Sajjad A, Giguère NJ, Holley MP, Stokes HW Mobilization of a Tn402-like class 1 integron with a novel cassette array via flanking miniature inverted-repeat transposable element-like structures. Appl Environ Microbiol 2009, 75:6002-6004.
26. Jones LA, McIver CJ, Kim MJ, Rawlinson WD, White PA The aadB gene cassette is associated with blaSHV genes in Klebsiella species producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 2005, 49:794-797.
27. Furtado GH, Gales AC, Perdiz LB, Santos AF, Medeiros EA Prevalence and clinical outcomes of episodes of ventilator-associated pneumonia caused by SPM-1-producing and non-producing imipenem-resistant Pseudomonas aeruginosa. Rev Soc Bras Med Trop 2011, 44:604-606.
28. Giske CG, Libisch B, Colinon C, et al. Establishing clonal relationships between VIM-1-like metallo-β-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multi-locus sequence typing. J Clin Microbiol 2006, 44:4309-4315.
29. Juan C, Zamorano L, Mena A, Albertí S, Pérez JL, Oliver A Metallo-β-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones. J Antimicrob Chemother 2010, 65:474-478.
30. Kouda S, Ohara M, Onodera M, et al. Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the blaIMP-1 gene cassette in Hiroshima. J Antimicrob Chemother 2009, 64:46-51.
31. Kitao T, Tada T, Tanaka M, et al. Emergence of a novel multidrug-resistant Pseudomonas aeruginosa strain producing IMP-type metallo-β-lactamases and AAC(6')-Iae in Japan. Int J Antimicrob Agents 2012, 39:518-521.
32. Yoo JS, Yang JW, Kim HM, et al. Dissemination of genetically related IMP-6-producing multidrug-resistant Pseudomonas aeruginosa ST235 in South Korea. Int J Antimicrob Agents 2012, 39:300-304.
33. Slekovec C, Plantin J, Cholley P, et al. Tracking down antibiotic-resistant Pseudomonas aeruginosa isolates in a wastewater network. PLoS One 2012, 7:e49300.
34. Pollini S, Antonelli A, Venturelli C, et al. Acquisition of plasmid-borne blaIMP-19 gene by a VIM-1-positive Pseudomonas aeruginosa of the sequence type 235 epidemic lineage. J Antimicrob Chemother 2013, 68:722-724.
35. Pollini S, Maradei S, Pecile P, et al. FIM-1, a new acquired metallo-β-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy. Antimicrob Agents Chemother 2013, 57:410-416.
36. Janvier F, Jeannot K, Tessé S, et al. Molecular characterisation of blaNDM-1 in a ST235 Pseudomonas aeruginosa isolate, France. Antimicrob Agents Chemother 2013, 57:3408-3411.
37. Tuon FF, Gortz LW, Rocha JL Risk factors for pan-resistant Pseudomonas aeruginosa bacteraemia and the adequacy of antibiotic therapy. Braz J Infect Dis 2012, 16:351-356.
38. Glupczynski Y, Bogaerts P, Deplano A, et al. Detection and characterization of class A extended-spectrum-β-lactamase-producing Pseudomonas aeruginosa isolates in Belgian hospitals. J Antimicrob Chemother 2010, 65:866-871.
39. Sardelic S, Bedenic B, Colinon-Dupuich C, et al. Infrequent finding of metallo-β-lactamase VIM-2 in carbapenem-resistant Pseudomonas aeruginosa strains from Croatia. Antimicrob Agents Chemother 2012, 56:2746-2749.
40. Lepsanovic Z, Libisch B, Tomanovic B, Nonkovici Z, Balogh B, Füzi M Characterisation of the first VIM metallo-β-lactamase-producing Pseudomonas aeruginosa clinical isolate in Serbia. Acta Microbiol Immunol Hung 2008, 55:447-454.
41. Koutsogiannou M, Drougka E, Liakopoulos A, et al. Spread of multidrug-resistant Pseudomonas aeruginosa clones in a university hospital. J Clin Microbiol 2013, 51:665-668.
42. Seok Y, Bae IK, Jeong SH, Kim SH, Lee H, Lee K Dissemination of IMP-6 metallo-β-lactamase-producing Pseudomonas aeruginosa sequence type 235 in Korea. J Antimicrob Chemother 2011, 66:2791-2796.
43. Hernandez J, Bonnedahl J, Eliasson I, et al. Global disseminated human pathogenic Escherichia coli of O25b-ST131 clone, harbouring blaCTX-M15, found in Glaucous-winged gull at remote Commander Islands, Russia. Environ Micro Reps 2010, 2:329-332.
44. Benskin CMH, Wilson K, Jones K, Hartley IR Bacterial pathogens in wild birds: a review of frequency and effects of infection. Biol Rev 2009, 84:349-373.